Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TNXP is expected to report earnings to fall 12.97% to -254 cents per share on August 10

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports

Q2'26

Est.

$-2.55

Q1'26

Missed

by $0.35

Q4'25

Missed

by $0.79

Q3'25

Est.

$-3.59

Q2'25

Beat

by $2.97

The last earnings report on May 11 showed earnings per share of -293 cents, missing the estimate of -257 cents. With 111.00K shares outstanding, the current market capitalization sits at 190.65M.

View a ticker or compare two or three

Compare

TNXP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TNXP